CJC-1295 NO DAC (MOD GRF 1-29) 2mg

Product Overview

CJC-1295 No DAC, commonly referred to as Modified GRF 1-29 (MOD GRF 1-29), is a truncated and stabilized analogue of the endogenous growth hormone-releasing hormone (GHRH). Unlike its DAC-conjugated counterpart, this variant does not incorporate a Drug Affinity Complex, resulting in a shorter active half-life that makes it a highly targeted tool for pulse-based in vitro and in vivo research protocols. Available at Revo Peptide, this compound is positioned as a premium research-grade reagent for scientists investigating GH secretagogue pathways, pituitary signalling, and neuroendocrine biology. Researchers looking to buy CJC-1295 No DAC online will find Revo Peptide’s offering competitively priced with rigorous quality assurance at every production stage.

Peptide Structure & Amino Acid Sequence

MOD GRF 1-29 is a 29-residue peptide derived from the first 29 amino acids of endogenous GHRH, with four strategic amino acid substitutions engineered to resist enzymatic degradation and improve receptor binding affinity. The confirmed full sequence is:

H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂

The incorporation of D-Ala at position 2 and the C-terminal amidation (–NH₂) are key structural features that differentiate this analogue from native GHRH(1-29), contributing to its enhanced stability profile in research buffer systems.

Chemical & Physical Characteristics

• Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
• Molecular Weight: 3,367.79 g/mol
• Appearance: White to off-white lyophilized powder
• Solubility: Soluble in aqueous buffer systems; compatible with standard laboratory reconstitution solvents
• CAS Number: 863288-34-0

These physicochemical parameters are consistent across production batches and are verified against reference standards prior to release by Revo Peptide’s quality control team.

Purity & Analytical Verification (HPLC & MS)

Each production batch of CJC-1295 No DAC supplied by Revo Peptide undergoes rigorous analytical testing to confirm identity and purity. Peptide purity is verified at >99% by reverse-phase high-performance liquid chromatography (RP-HPLC), with identity confirmed via mass spectrometry (MS). These dual-method verification protocols ensure that researchers receive a compound of exceptional consistency, minimising experimental variability and supporting reproducible outcomes across independent studies. Certificates of Analysis (CoA) reflecting HPLC chromatograms and MS data are available upon request, providing full analytical transparency for laboratory documentation and institutional compliance requirements.

Quality Control & Lyophilization Integrity

Revo Peptide applies pharmaceutical-grade lyophilization processes to all peptide vials. Freeze-drying under controlled temperature and pressure conditions ensures the removal of residual moisture, preserving the structural integrity of the peptide chain during storage and transit. Each sealed vial undergoes visual inspection and weight verification before dispatch. The lyophilized format not only extends shelf stability but also ensures that the peptide remains in its most research-ready state upon arrival at the end user’s laboratory.

Safety, Handling & Laboratory Precautions

CJC-1295 No DAC (MOD GRF 1-29) is a research chemical intended exclusively for use by trained scientific personnel in appropriately equipped laboratory environments. Standard laboratory personal protective equipment (PPE) — including nitrile gloves, safety eyewear, and a lab coat — should be worn during handling. Researchers should consult relevant institutional safety guidelines and applicable local regulations before working with this compound. This product is not approved for human or veterinary administration and must be stored and handled in compliance with institutional biosafety protocols.

Reconstitution, Packaging & Storage

CJC-1295 No DAC is supplied as a lyophilized powder in a sealed, sterile-capped glass vial. For laboratory reconstitution, researchers should use an appropriate aqueous solvent such as bacteriostatic water or sterile phosphate-buffered saline (PBS), following institutional SOPs for peptide preparation in research settings. Reconstitution volumes and concentrations should be determined by the supervising researcher based on the specific assay or experimental protocol in use.

• Storage (lyophilized): Store at −20°C, protected from light and moisture
• Storage (reconstituted): Store at 4°C and use within the timeframe specified in your laboratory’s standard operating procedures
• Avoid: Repeated freeze-thaw cycles, exposure to direct light, and high-humidity environments

Intended Research Use & Market Positioning

MOD GRF 1-29 is widely referenced in peer-reviewed neuroendocrinology and metabolic research literature as a tool for studying pulsatile GH release, GHRH receptor pharmacology, and downstream IGF-1 pathway interactions. Revo Peptide supplies this compound exclusively to researchers, universities, pharmaceutical developers, and accredited laboratories engaged in non-clinical scientific investigation. This product is not intended for use in humans, animals, or any clinical or diagnostic setting.

Ordering, Availability & Fulfillment

Revo Peptide offers CJC-1295 No DAC (MOD GRF 1-29) for sale online with streamlined ordering, secure checkout, and prompt dispatch. Bulk purchasing options are available for research institutions requiring larger quantities, with volume-based savings automatically applied at checkout. Whether you are looking to order MOD GRF 1-29 for a single experiment or establish an ongoing supply arrangement, Revo Peptide provides consistent stock availability, competitive best pricing, and reliable fulfillment to support uninterrupted research programmes.

Legal & Regulatory Disclaimer

For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications. CJC-1295 No DAC (MOD GRF 1-29) is sold exclusively as a laboratory research reagent. Revo Peptide makes no representations regarding the safety, efficacy, or suitability of this compound for any application beyond in vitro and non-clinical scientific research. All purchasers are solely responsible for ensuring that acquisition, possession, and use of this product comply with all applicable local, national, and international laws and regulations. This product has not been evaluated or approved by any regulatory authority for therapeutic or diagnostic use.